The University of Tennessee Graduate School of Medicine, Knoxville

The Department of Medicine

Benjamin Shepple, MD

Clinical Assistant Professor
Division of Cardiology

Research Focus

Dr. Shepple's interest is in next generation cardiac imaging. UTMC is the world's lead enroller in the Aurora clinical trial, a phase-3 evaluation of the radiotracer Flurpiridaz (18F) during PET myocardial perfusion imaging for the detection of hemodynamically significant coronary artery disease as compared to SPECT myocardial perfusion imaging and invasive coronary angiography. Among PET radiotracers, Flurpiridaz has a number of advantageous properties including a longer half-life, better linearity with myocardial blood flow, and reduced positron range. It is the expectation that these properties will result in clinical images with improved accuracy in the non-invasive assessment of coronary artery disease. Further, Flurpiridaz PET imaging exposes patients to significantly less radiation as compared to stand SPECT imaging.


Taylor University, Upland, IN, 2001-2005

Medical School
Indiana University School of Medicine, Indianapolis, IN, 2005-2009

University of Virginia, Charlottesville, VA, 2009-2012

University of Virginia, Charlottesville, VA, Cardiovascular Medicine Fellowship, 2012-2015
Chief Cardiology Fellow, 2014-2015


American Board of Internal Medicine, 2012
American Board of Internal Medicine - Cardiovascular Disease, Eligible 2015


Support The University of Tennessee Graduate School of Medicine

The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290

Copyright © 2019